| # | Drug | Count |
|---|---|---|
| 0 | NICOTINE | 445 |
| 1 | BUPRENORPHINE | 205 |
| 2 | ESTRADIOL | 195 |
| 3 | METHYLPHENIDATE | 140 |
| 4 | NICOTINE POLACRILEX | 84 |
| 5 | ESTRADIOL GEL 0.1% | 47 |
| 6 | ESTRADIOL TRANSDERMAL | 47 |
| 7 | ESTRADIOL, | 47 |
| 8 | LEVOTHYROXINE SODIUM | 43 |
| 9 | SELEGILINE | 42 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ALUMINUM ZIRCONIUM PENTACHLOROHYDREX GLY | 1 | 0.2000 |
| 1 | HOMOSALATE, MERADIMATE, OCTINOXATE, ZINC OXIDE, AND OCTOCRYLENE | 1 | 0.1250 |
| 2 | ALUMINUM ZIRCONIUM TRICHLOROHYDREX GLY | 1 | 0.0909 |
| 3 | ESTRADIOL/NORETHINDRONE ACETATE TRANSDERMAL SYSTEM | 1 | 0.0357 |
| 4 | ADAPALENE AND BENZOYL PEROXIDE | 1 | 0.0185 |
| 5 | SELEGILINE | 42 | 0.0140 |
| 6 | L-PHENYLALANINE | 1 | 0.0127 |
| 7 | NICOTINE | 445 | 0.0110 |
| 8 | CLONIDINE TRANSDERMAL SYSTEM | 23 | 0.0108 |
| 9 | BERDAZIMER | 1 | 0.0105 |
| # | Drug class | Count |
|---|---|---|
| 0 | Cholinergic Nicotinic Agonist [EPC] | 493 |
| 1 | Estrogen [EPC] | 242 |
| 2 | Partial Opioid Agonist [EPC] | 205 |
| 3 | Central Nervous System Stimulant [EPC] | 148 |
| 4 | Nonsteroidal Anti-inflammatory Drug [EPC] | 71 |
| 5 | Benzodiazepine [EPC] | 63 |
| 6 | Monoamine Oxidase Inhibitor [EPC] | 42 |
| 7 | Monoamine Oxidase Type B Inhibitor [EPC] | 42 |
| 8 | Progestin [EPC] | 41 |
| 9 | Central alpha-2 Adrenergic Agonist [EPC] | 40 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Monoamine Oxidase Inhibitor [EPC] | 42 | 0.0136 |
| 1 | Cholinergic Nicotinic Agonist [EPC] | 493 | 0.0081 |
| 2 | Tubulin Inhibiting Agent [EPC] | 1 | 0.0034 |
| 3 | Partial Opioid Agonist [EPC] | 205 | 0.0022 |
| 4 | Nonergot Dopamine Agonist [EPC] | 30 | 0.0019 |
| 5 | Central Nervous System Stimulant [EPC] | 148 | 0.0017 |
| 6 | Estrogen [EPC] | 242 | 0.0013 |
| 7 | Provitamin D2 Compound [EPC] | 35 | 0.0012 |
| 8 | Aryl Hydrocarbon Receptor Agonist [EPC] | 2 | 0.0010 |
| 9 | Progesterone [EPC] | 23 | 0.0010 |